The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Barry M. Brenner

Brigham and Women's Hospital

Harvard Medical School

Boston

Massachusetts 02115-6195

USA

[email]@partners.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115-6195, USA. 2002 - 2005
  • Harvard Medical School, Boston, Massachusetts, USA. 2004
  • Renal Division, Brigham and Women's Hospital, Boston, MA 02115, USA. 2001 - 2003
  • Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, USA. 2001

References

  1. Cardiovascular and renal progression factors in chronic kidney disease: a colloquium in honor of John H. Dirks ISN World Congress of Nephrology Singapore, June 26, 2005. Brenner, B.M. Kidney Int. (2005) [Pubmed]
  2. Renoprotection by enzyme replacement therapy. Brenner, B.M., Grünfeld, J.P. Curr. Opin. Nephrol. Hypertens. (2004) [Pubmed]
  3. AMGEN International Prize: the history and future of renoprotection. Brenner, B.M. Kidney Int. (2003) [Pubmed]
  4. Remission of renal disease: recounting the challenge, acquiring the goal. Brenner, B.M. J. Clin. Invest. (2002) [Pubmed]
  5. Vasopeptidase inhibition affords greater renoprotection than angiotensin-converting enzyme inhibition alone. Taal, M.W., Nenov, V.D., Wong, W., Satyal, S.R., Sakharova, O., Choi, J.H., Troy, J.L., Brenner, B.M. J. Am. Soc. Nephrol. (2001) [Pubmed]
  6. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. Brenner, B.M., Cooper, M.E., de Zeeuw, D., Keane, W.F., Mitch, W.E., Parving, H.H., Remuzzi, G., Snapinn, S.M., Zhang, Z., Shahinfar, S. N. Engl. J. Med. (2001) [Pubmed]
 
WikiGenes - Universities